SCHEMBL4911463

SCHEMBL4911463

Cc1ncccc1Oc1ncc(C#N)cc1NS(=O)(=O)c1cc(Cl)c(Cl)s1

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 10/20 0.71
CCR4 P51679 4/20 0.53
CYP3A4 P08684 2/20 0.53
CYP2C9 P11712 2/20 0.53
CYP2C19 P33261 2/20 0.53
PTGES2 Q9H7Z7 1/20 0.41
SLC22A12 Q96S37 3/20 0.40
ACLY P53396 1/20 0.39
SCN9A Q15858 1/20 0.37
KIT P10721 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CCR5 P51681 1/20 0.37
PIK3CA P42336 1/20 0.37
CCR1 P32246 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4909634 0.85 CCR2 (0.51) CCR2CCR4CYP3A4CYP2C9CYP2C19
SCHEMBL4912322 0.83 CCR2 (1.00) CCR2CCR4CYP3A4CYP2C9CYP2C19
SCHEMBL14006392 0.77 CCR2 (0.55) CCR2CCR4CYP3A4CYP2C9CYP2C19
SCHEMBL4901548 0.76 CCR2 (0.54) CCR2CCR4CYP3A4CYP2C9CYP2C19
SCHEMBL4913296 0.76 CCR2 (0.71) CCR2CCR4CYP3A4CYP2C9CYP2C19
SCHEMBL14006344 0.75 CCR2 (0.55) CCR2CCR4CYP3A4CYP2C9CYP2C19
SCHEMBL4904763 0.75 CCR2 (0.67) CCR2CCR4CYP3A4CYP2C9CYP2C19
SCHEMBL4913044 0.72 CCR2 (0.69) CCR2CCR4CYP3A4CYP2C9CYP2C19
SCHEMBL4910002 0.72 CCR2 (0.69) CCR2CCR4CYP3A4CYP2C9CYP2C19
SCHEMBL4912872 0.72 CCR2 (0.66) CCR2CCR4CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors CCR2, CCR1, CCRL2 CCR2 1/4885CCR4 8/4885CYP3A4 1414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.